Regulatory agencies have previously found unlicensed weight loss treatments containing banned drugs like Sibutramine (a heart-risk stimulant removed from the market)
Their BELIEVE trial, presented at ADA in June 2025, showed 22.1% weight loss with 92.8% from fat at 72 weeks
A cyclic peptide analog of -MSH that binds melanocortin receptors, studied for melanogenesis and related pathways in research settings
I get this question every week, and it matters because these are not all the same drug
To validate these findings, multiple sensitivity analyses were carried out using a variety of selection criteria and models that integrated various covariates (Table S7)
For those with PCOS considering GLP-1 medications, the message is straightforward: these treatments hold promise, but they work best as part of a carefully managed, personalized care plan